0001571049-15-006999.txt : 20150824
0001571049-15-006999.hdr.sgml : 20150824
20150824170032
ACCESSION NUMBER: 0001571049-15-006999
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150820
FILED AS OF DATE: 20150824
DATE AS OF CHANGE: 20150824
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP
CENTRAL INDEX KEY: 0001069899
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 131840497
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR
STREET 2: 300 FRANK W. BURR BLVD., SUITE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
BUSINESS PHONE: 201-329-7300
MAIL ADDRESS:
STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR
STREET 2: 300 FRANK W. BURR BLVD., SUITE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
FORMER COMPANY:
FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC
DATE OF NAME CHANGE: 19980908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carlson Gerald K
CENTRAL INDEX KEY: 0001601343
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36410
FILM NUMBER: 151071518
MAIL ADDRESS:
STREET 1: 2496 OLD BEACH ROAD
CITY: WAYZATA
STATE: MN
ZIP: 55391
FORMER NAME:
FORMER CONFORMED NAME: Carlson Gerald Kenneth
DATE OF NAME CHANGE: 20140227
4
1
t1502007_carlson-f4.xml
OWNERSHIP DOCUMENT
X0306
4
2015-08-20
0
0001069899
PHIBRO ANIMAL HEALTH CORP
PAHC
0001601343
Carlson Gerald K
300 FRANK W. BURR BLVD., STE 21
TEANECK,
NJ
07666
1
1
0
0
Chief Operating Officer
Class A Common Stock
2015-08-20
4
M
0
2500
11.83
A
2500
D
Class A Common Stock
2015-08-20
4
S
0
2500
36.5474
D
0
D
Class A Common Stock
2015-08-21
4
M
0
13500
11.83
A
13500
D
Class A Common Stock
2015-08-21
4
S
0
13500
34.7639
D
0
D
Option to purchase Class A Common Stock
11.83
2015-08-20
4
M
0
2500
0
D
2013-04-29
2019-02-28
Class A Common Stock
2500
181550
D
Option to purchase Class A Common Stock
11.83
2015-08-21
4
M
0
13500
0
D
2013-04-29
2019-02-28
Class A Common Stock
13500
168050
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2015.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.37 to $36.59, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.95 to $35.38, inclusive.
/s/ Thomas G. Dagger, as Attorney-in-Fact for Gerald K. Carlson
2015-08-24